Vivos Therapeutics, Inc. (NASDAQ:VVOS) Q4 2023 Earnings Call

Vivos Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-3.05 EPS, expectations were $-1.9.

Related Keywords

Denver , Colorado , United States , Scott Henry , Kirk Huntsman , Julie Gannon , Nasdaq , Vivos Therapeutics Inc , Drug Administration , Exchange Commission , Philips , Vivos Institute , Vivos Therapeutics , Call Transcript March , Vivos Therapeutics Fourth Quarter , Full Year , Investor Relations , Vivo Investor Relations Officer , Vivo Chairman , Chief Executive Officer , Brad Amman , Chief Financial , Securities Act , Exchange Act , Chief Financial Officer , Chief Financial Officer Brad Amman , Although Vivo , That Tax Social Security , Highest Housing Costs , Lucas Ward ,